Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Robek

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Hepatology (Baltimore, Md.)|August 22, 2014
Cytidine deamination and cccDNA degradation: A new approach for curing HBV?Siyuan Ding, Michael D Robek
Nature Immunology|July 22, 2014
Peroxisomal MAVS activates IRF1-mediated IFN-λ productionSiyuan Ding, Michael D Robek
The American Journal of Pathology|November 20, 2012
Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitisMelissa A Cobleigh, Michael D Robek
Viruses|October 14, 2011
Interferon-λ in HCV Infection and TherapyNicole E Pagliaccetti, Michael D Robek
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 22, 2010
Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virusNicole E Pagliaccetti, Michael D Robek
Current Opinion in Virology|May 16, 2021
Innate immunity and HBV persistenceCarolina Chiale, Anthony M Marchese, Michael D Robek
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 30, 2009
Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteinsPrasanthi Bandi, Nicole E Pagliaccetti, Michael D Robek
Journal of Virology|February 27, 2009
Hepatitis B virus replication and release are independent of core lysine ubiquitinationMayra L Garcia, Rushelle Byfield, Michael D Robek
Journal of Virology|December 28, 2012
A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic miceMelissa A Cobleigh, Xin Wei, Michael D Robek
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
An ELISPOT-Based Assay to Measure HBV-Specific CD8<sup>+</sup> T Cell Responses in Immunocompetent MiceTracy D Reynolds, Safiehkhatoon Moshkani, Michael D Robek
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Hepatology (Baltimore, Md.)|August 22, 2014
Cytidine deamination and cccDNA degradation: A new approach for curing HBV?Siyuan Ding, Michael D Robek
Nature Immunology|July 22, 2014
Peroxisomal MAVS activates IRF1-mediated IFN-λ productionSiyuan Ding, Michael D Robek
The American Journal of Pathology|November 20, 2012
Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitisMelissa A Cobleigh, Michael D Robek
Viruses|October 14, 2011
Interferon-λ in HCV Infection and TherapyNicole E Pagliaccetti, Michael D Robek
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 22, 2010
Interferon-lambda in the immune response to hepatitis B virus and hepatitis C virusNicole E Pagliaccetti, Michael D Robek
Current Opinion in Virology|May 16, 2021
Innate immunity and HBV persistenceCarolina Chiale, Anthony M Marchese, Michael D Robek
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 30, 2009
Inhibition of type III interferon activity by orthopoxvirus immunomodulatory proteinsPrasanthi Bandi, Nicole E Pagliaccetti, Michael D Robek
Journal of Virology|February 27, 2009
Hepatitis B virus replication and release are independent of core lysine ubiquitinationMayra L Garcia, Rushelle Byfield, Michael D Robek
Journal of Virology|December 28, 2012
A vesicular stomatitis virus-based therapeutic vaccine generates a functional CD8 T cell response to hepatitis B virus in transgenic miceMelissa A Cobleigh, Xin Wei, Michael D Robek
Methods in Molecular Biology (Clifton, N.J.)|December 16, 2016
An ELISPOT-Based Assay to Measure HBV-Specific CD8<sup>+</sup> T Cell Responses in Immunocompetent MiceTracy D Reynolds, Safiehkhatoon Moshkani, Michael D Robek
Pageof 5